Cryo-Cell International, Inc. CCEL

Company Overview

Cryo-Cell International, Inc. (CCEL) is a biotechnology services company specializing in the collection, processing, and long-term storage of stem cells derived from umbilical cord blood and cord tissue. The company operates within the biotechnology, life sciences, and healthcare services industries, with a primary focus on preventative medicine and regenerative medicine support services. Its core customers are expectant parents, hospitals, and healthcare providers seeking private stem cell banking solutions.

Founded in 1989, Cryo-Cell is recognized as one of the first private cord blood banks in the world. Over time, the company expanded from cord blood banking into cord tissue preservation as clinical research increasingly supported the potential therapeutic applications of mesenchymal stem cells. Cryo-Cell’s long operating history, early-mover advantage, and exclusive focus on private (family) banking differentiate it from public or hybrid stem cell banks.